Back
 PP  Vol.4 No.3 , June 2013
Research of Quality Standards for Stachydrine Hydrochloride in Chinese Medicine TJF Granule
Abstract: A high-performance liquid chromatographic method was applied to the determination of stachydrine hydrochloride concentration in TJF granule (Chinese name: Tiao-Jing-Fang), using a mobile phase of methanol-acetonitrile (50:50, v/v) by the Agilent Kromasi NH2 column (250 mm × 4.6 mm, 5 μm, S/N: 22N25110). Detection wavelength was 201 nm. The result revealed good linearity of stachydrine hydrochloride and was obtained within the range of 0.20 - 1.98 μg/mL (R = 0.9995). The average recovery was 97.01%; the relative standard deviation (RSD) was 0.19%. To the best of our knowledge, this is the first report dedicated to the determination of stachydrine hydrochloride by the evaporative light scattering detector-high-performance liquid chromatographic (ELSD-HPLC) method.
Cite this paper: Y. Lu, W. Yu, P. Shen, T. Khoo and C. Wiart, "Research of Quality Standards for Stachydrine Hydrochloride in Chinese Medicine TJF Granule," Pharmacology & Pharmacy, Vol. 4 No. 3, 2013, pp. 277-282. doi: 10.4236/pp.2013.43040.
References

[1]   China Pharmacopoeia Committee, “Section One,” In: China Pharmacopoeia Committee, Ed., Chinese Pharmacopoeia 2005 English Edition, Chemical Industry Press (CIP), Beijing, 2005, pp. 203-205.

[2]   Z. S. Huang, “Formula of Promoting Blood Circulation for Removing Blood Stasis,” In: Z. S. Huang, Ed., Chinese Materia Medica, People’s Medical Publication, Beijing, 2007, pp. 303-317.

[3]   Z. Z. Tao, “Blood-Activating Formula,” In: Z. Z. Tao, Ed., Chinese Materia Medica, People’s Medical Publications, Beijing, 2006, pp. 346-387.

[4]   F. L. Yin, “Menstruation Disorder,” In: F. L. Yin, Ed., Internal Medicine, Shanghai Science and Technology Publications, Shanghai, 2001, pp. 113-117.

[5]   C. H, Zeng and W. H. Dai, “Emmeniopathy,” In: C. H, Zeng and W. H. Dai, Eds., Internal Medicine, People’s Medical Publications, Beijing, 2003, pp. 208-212.

[6]   Y. H. Q. Ou, “Menstruation Diseases,” In: Y. H. Q. Ou, Ed., Gynecology of Traditional Chinese Medicine, People’s Medical Publications, Beijing, 2006, pp. 52-96.

[7]   X. J. Chen, “Emmeniopathy,” In: X. J. Chen, Ed., Internal Medicine of Traditional Chinese Medicine, Shanghai Science and Technology Publication, Shanghai, 2002, pp. 268-271.

[8]   Y. K. Wang and F. C. Wang, “Menstruation Diseases,” In: Y. K. Wang and F. C. Wang, Eds., Gynecology of Traditional Chinese Medicine, Chinese Press of Traditional Chinese Medicine, Beijing, 2009, pp. 31-78.

[9]   Y. Z. Zhang, “Menstruation Disorder,” In: Y. Z. Zhang, Ed., Traditional Chinese Gynecology, Chinese Press of Traditional Chinese Medicine, Beijing, 2005, pp. 25-63.

[10]   X. M. Liang, Y. Wang and X. M. Zhang, “Determination of Stachydrine Hydrochloride in Herba Leonuri Granules by TLC,” Chinese Traditional Patent Medicine, Vol. 7, No. 8, 2006, pp. 1073-10744.

[11]   J. L. Ruan, “Research Developments of Herba Leonuri on the Chemical, Pharmacological and Clinical Researches,” Journal of Chinese Herbal Medicine, Vol. 11, No. 6, 2003, pp. 15-19.

[12]   X. Y. Meng and J. Q. Yang, “Research Developments of Herba Leonuri,” Heilongjiang Medical Journal, Vol. 5, No. 1, 2007, pp. 467-468.

 
 
Top